PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 118 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $7,000 | -12.5% | 2,522 | 0.0% | 0.00% | – |
| Q4 2021 | $8,000 | -55.6% | 2,522 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $18,000 | -21.7% | 2,522 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $23,000 | -8.0% | 2,522 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $25,000 | -3.8% | 2,522 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $26,000 | +4.0% | 2,522 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $25,000 | -3.8% | 2,522 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $26,000 | +23.8% | 2,522 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $21,000 | -4.5% | 2,522 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $22,000 | -18.5% | 2,522 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $27,000 | -15.6% | 2,522 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $32,000 | -67.3% | 2,522 | 0.0% | 0.00% | -80.0% |
| Q1 2019 | $98,000 | +92.2% | 2,522 | 0.0% | 0.01% | +66.7% |
| Q4 2018 | $51,000 | -56.0% | 2,522 | 0.0% | 0.00% | -40.0% |
| Q3 2018 | $116,000 | -22.1% | 2,522 | 0.0% | 0.01% | -28.6% |
| Q2 2018 | $149,000 | -13.4% | 2,522 | 0.0% | 0.01% | -12.5% |
| Q1 2018 | $172,000 | -30.9% | 2,522 | 0.0% | 0.01% | -27.3% |
| Q4 2017 | $249,000 | +6.9% | 2,522 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $233,000 | +5.9% | 2,522 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $220,000 | +147.2% | 2,522 | +5.9% | 0.01% | +175.0% |
| Q1 2017 | $89,000 | -81.6% | 2,382 | +16.2% | 0.00% | -87.5% |
| Q1 2015 | $484,000 | +24.7% | 2,050 | 0.0% | 0.03% | +18.5% |
| Q4 2014 | $388,000 | -21.8% | 2,050 | -1.4% | 0.03% | -25.0% |
| Q3 2014 | $496,000 | – | 2,080 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
| Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
| CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
| BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
| WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
| TOBAM | 318,384 | $23,994,000 | 0.94% |
| Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
| Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
| CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |